Nu Skin Enterprises (NUS) PT Raised to $77.00 at Deutsche Bank

Nu Skin Enterprises (NYSE:NUS) had its target price boosted by research analysts at Deutsche Bank from $75.00 to $77.00 in a report issued on Friday. The firm presently has a “buy” rating on the stock. Deutsche Bank’s price target would indicate a potential upside of 11.48% from the company’s current price.

A number of other equities analysts have also recently commented on the company. Stifel Nicolaus lifted their price target on Nu Skin Enterprises from $50.00 to $57.00 and gave the stock a “sell” rating in a research note on Friday. Pivotal Research reaffirmed a “buy” rating and issued a $90.00 price target on shares of Nu Skin Enterprises in a research note on Friday. ValuEngine raised Nu Skin Enterprises from a “hold” rating to a “buy” rating in a research note on Friday, February 2nd. Citigroup reaffirmed a “buy” rating and issued a $81.00 price target (up from $70.00) on shares of Nu Skin Enterprises in a research note on Tuesday, January 23rd. Finally, Zacks Investment Research raised Nu Skin Enterprises from a “sell” rating to a “hold” rating and set a $78.00 price target on the stock in a research note on Saturday, December 30th. Two research analysts have rated the stock with a sell rating, two have issued a hold rating and five have issued a buy rating to the stock. The company has an average rating of “Hold” and an average target price of $71.29.

Shares of Nu Skin Enterprises (NYSE NUS) opened at $69.07 on Friday. The firm has a market capitalization of $3,831.34, a P/E ratio of 29.14, a P/E/G ratio of 2.26 and a beta of 1.46. Nu Skin Enterprises has a 12-month low of $47.10 and a 12-month high of $74.45. The company has a debt-to-equity ratio of 0.44, a current ratio of 1.78 and a quick ratio of 1.18.

Nu Skin Enterprises (NYSE:NUS) last released its earnings results on Thursday, February 15th. The company reported $1.20 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.19 by $0.01. The company had revenue of $666.20 million during the quarter, compared to the consensus estimate of $667.39 million. Nu Skin Enterprises had a return on equity of 25.25% and a net margin of 5.68%. Nu Skin Enterprises’s quarterly revenue was up 25.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.79 EPS. analysts expect that Nu Skin Enterprises will post 3.65 earnings per share for the current fiscal year.

In other Nu Skin Enterprises news, Chairman Steven Lund sold 42,000 shares of Nu Skin Enterprises stock in a transaction that occurred on Wednesday, December 20th. The stock was sold at an average price of $68.11, for a total value of $2,860,620.00. Following the transaction, the chairman now directly owns 4,769 shares of the company’s stock, valued at approximately $324,816.59. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Insiders sold a total of 195,978 shares of company stock worth $13,512,733 over the last ninety days. Insiders own 5.20% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of NUS. Wells Fargo & Company MN increased its stake in shares of Nu Skin Enterprises by 14.8% during the second quarter. Wells Fargo & Company MN now owns 49,408 shares of the company’s stock valued at $3,105,000 after buying an additional 6,361 shares during the period. Virtu KCG Holdings LLC purchased a new position in shares of Nu Skin Enterprises during the second quarter valued at approximately $255,000. Janus Henderson Group PLC purchased a new position in shares of Nu Skin Enterprises during the second quarter valued at approximately $1,973,000. Cubist Systematic Strategies LLC purchased a new position in shares of Nu Skin Enterprises during the second quarter valued at approximately $573,000. Finally, The Manufacturers Life Insurance Company increased its stake in shares of Nu Skin Enterprises by 2.2% during the second quarter. The Manufacturers Life Insurance Company now owns 73,141 shares of the company’s stock valued at $4,596,000 after buying an additional 1,581 shares during the period. 77.00% of the stock is currently owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: “Nu Skin Enterprises (NUS) PT Raised to $77.00 at Deutsche Bank” was originally reported by StockNewsTimes and is the property of of StockNewsTimes. If you are viewing this article on another publication, it was copied illegally and republished in violation of U.S. and international copyright and trademark legislation. The legal version of this article can be viewed at https://stocknewstimes.com/2018/02/18/nu-skin-enterprises-nus-pt-raised-to-77-00-at-deutsche-bank-2.html.

Nu Skin Enterprises Company Profile

Nu Skin Enterprises, Inc is a direct selling company that develops and distributes personal care products and nutritional supplements, and a range of other products and services. The Company offers anti-aging personal care products and nutritional supplements under its Nu Skin and Pharmanex brands. The Nu Skin brand offers a range of products, including ageLOC Me customized skin care system, ageLOC Spa systems and ageLOC Transformation anti-aging skin care system.

Analyst Recommendations for Nu Skin Enterprises (NYSE:NUS)

Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply